FDA Will Drive Changes for Contract Business

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-11-02-2003, Volume 27, Issue 11

As FDA tries to bring pharmaceutical manufacturing into the 21st century, competitive dynamics in contract manufacturing are likely to change in favor of companies that have greater manufacturing expertise and the means to invest in new technologies.

Related Content:

OutsourcingOutsourcing OutlookPharmaceutical Technology-11-02-2003
Samsung Biologics Expands Strategic Manufacturing Agreement with Bristol Myers Squibb
CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells
Illumina Establishes New Center in India to Expand Genomics Capabilities